State Street’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-612,969
| Closed | -$588K | – | 4698 |
|
|
2023
Q2 | $588K | Sell |
612,969
-62,400
| -9% | -$61.7K | ﹤0.01% | 3655 |
|
|
2023
Q1 | $507K | Buy |
675,369
+101,500
| +18% | +$74.1K | ﹤0.01% | 3742 |
|
|
2022
Q4 | $211K | Sell |
573,869
-49,700
| -8% | -$21K | ﹤0.01% | 4081 |
|
|
2022
Q3 | $268K | Sell |
623,569
-98,200
| -14% | -$96.5K | ﹤0.01% | 4014 |
|
|
2022
Q2 | $563K | Sell |
721,769
-2,616,547
| -78% | -$2.31M | ﹤0.01% | 3788 |
|
|
2022
Q1 | $4.31M | Sell |
3,338,316
-1,404,723
| -30% | -$1.29M | ﹤0.01% | 3261 |
|
|
2021
Q4 | $6.02M | Sell |
4,743,039
-12,393,580
| -72% | -$22.2M | ﹤0.01% | 3148 |
|
|
2021
Q3 | $37.4M | Buy |
17,136,619
+5,936,588
| +53% | +$16.2M | ﹤0.01% | 2018 |
|
|
2021
Q2 | $42M | Sell |
11,200,031
-1,926,561
| -15% | -$6.7M | ﹤0.01% | 1981 |
|
|
2021
Q1 | $42.8M | Buy |
13,126,592
+2,539,908
| +24% | +$9.11M | ﹤0.01% | 1863 |
|
|
2020
Q4 | $36.1M | Buy |
10,586,684
+3,707,862
| +54% | +$15.3M | ﹤0.01% | 1861 |
|
|
2020
Q3 | $28.1M | Buy |
6,878,822
+93,286
| +1% | +$355K | ﹤0.01% | 1830 |
|
|
2020
Q2 | $22.9M | Buy |
6,785,536
+1,533,171
| +29% | +$4.47M | ﹤0.01% | 1951 |
|
|
2020
Q1 | $12.2M | Buy |
5,252,365
+410,364
| +8% | +$1.12M | ﹤0.01% | 2158 |
|
|
2019
Q4 | $17.6M | Buy |
4,842,001
+497,048
| +11% | +$4.02M | ﹤0.01% | 2229 |
|
|
2019
Q3 | $36M | Sell |
4,344,953
-766,323
| -15% | -$6.2M | ﹤0.01% | 1668 |
|
|
2019
Q2 | $44M | Sell |
5,111,276
-316,908
| -6% | -$2.83M | ﹤0.01% | 1566 |
|
|
2019
Q1 | $58M | Sell |
5,428,184
-433,597
| -7% | -$4.64M | ﹤0.01% | 1354 |
|
|
2018
Q4 | $51.3M | Sell |
5,861,781
-115,031
| -2% | -$1.47M | ﹤0.01% | 1331 |
|
|
2018
Q3 | $100M | Buy |
5,976,812
+701,540
| +13% | +$15.2M | 0.01% | 1075 |
|
|
2018
Q2 | $111M | Buy |
5,275,272
+398,494
| +8% | +$7.38M | 0.01% | 968 |
|
|
2018
Q1 | $78.5M | Buy |
4,876,778
+764,041
| +19% | +$15.1M | 0.01% | 1136 |
|
|
2017
Q4 | $77.9M | Buy |
4,112,737
+1,356,301
| +49% | +$24.6M | 0.01% | 1161 |
|
|
2017
Q3 | $38.8M | Sell |
2,756,436
-264,127
| -9% | -$2.39M | ﹤0.01% | 1541 |
|
|
2017
Q2 | $22.5M | Buy |
3,020,563
+666,605
| +28% | +$4.36M | ﹤0.01% | 1899 |
|
|
2017
Q1 | $15.3M | Buy |
2,353,958
+733,651
| +45% | +$4.1M | ﹤0.01% | 2135 |
|
|
2016
Q4 | $7.18M | Sell |
1,620,307
-798,818
| -33% | -$3.35M | ﹤0.01% | 2494 |
|
|
2016
Q3 | $11.3M | Buy |
2,419,125
+477,075
| +25% | +$2.83M | ﹤0.01% | 2124 |
|
|
2016
Q2 | $12.8M | Buy |
1,942,050
+715,546
| +58% | +$5.06M | ﹤0.01% | 2071 |
|
|
2016
Q1 | $7.8M | Sell |
1,226,504
-1,537,195
| -56% | -$7.89M | ﹤0.01% | 2314 |
|
|
2015
Q4 | $16.7M | Sell |
2,763,699
-2,118,045
| -43% | -$12.1M | ﹤0.01% | 1849 |
|
|
2015
Q3 | $29.2M | Sell |
4,881,744
-132,396
| -3% | -$919K | ﹤0.01% | 1498 |
|
|
2015
Q2 | $34.3M | Buy |
5,014,140
+341,266
| +7% | +$2.17M | ﹤0.01% | 1492 |
|
|
2015
Q1 | $28.4M | Buy |
4,672,874
+1,291,265
| +38% | +$8.59M | ﹤0.01% | 1596 |
|
|
2014
Q4 | $23.4M | Buy |
3,381,609
+355,934
| +12% | +$2.62M | ﹤0.01% | 1687 |
|
|
2014
Q3 | $24.6M | Buy |
3,025,675
+242,896
| +9% | +$1.9M | ﹤0.01% | 1586 |
|
|
2014
Q2 | $22.6M | Sell |
2,782,779
-582,689
| -17% | -$4.42M | ﹤0.01% | 1737 |
|
|
2014
Q1 | $26.4M | Buy |
3,365,468
+658,564
| +24% | +$5.57M | ﹤0.01% | 1561 |
|
|
2013
Q4 | $24M | Sell |
2,706,904
-660,871
| -20% | -$5.9M | ﹤0.01% | 1619 |
|
|
2013
Q3 | $28.3M | Sell |
3,367,775
-174,413
| -5% | -$1.41M | ﹤0.01% | 1485 |
|
|
2013
Q2 | $26.4M | Buy |
+3,542,188
| New | +$27.2M | ﹤0.01% | 1466 |
|
State Street's SPPI Position: Q3 2023 in Review
State Street sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 612,969 shares — an estimated $588K sold.
State Street first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $111M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- State Street reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- State Street sold 612,969 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $588K.
- State Street first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
- State Street's Spectrum Pharmaceuticals Inc position peaked at $111M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.